SEQUENT SCIENTIFIC LTD. - 512529 - Amendment To Sequent Scientific Limited Employee Stock Option Plan 2020
The Board of Director on the recommendation of the Nomination and Remuneration Committee held August 07, 2023 approve the few amendments to the SeQuent Scientific Limited Employee Stock Option Plan. The Company will be seeking the approval of the shareholders for proposed amendments in the ensuing Annual General Meeting SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 (read with Part A of schedule III) of the Security and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, We would like to inform you that the Board of Director based on the recommendation of the Nomination and Remuneration Committee held on August 07, 2023 approved the appointment of Dr. Hari Babu Bodepudi (DIN : 01119678) as Additional Director (Non Executive Non Independent) wef August 07, 2023. Dr. Hari Babu Bodepudi will hold office until the conclusion of the ensuing Annual General Meeting of the Company and Company will seeking approval of the shareholders at the ensuing Annual General Meeting. Brief Profile and other information of aforesaid Director pursuant to SEBI Circular bearing reference SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is mentioned in Annexure A as enclosed herewith SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Friday, August 11, 2023, to discuss its Q1FY24 financial results. SEQUENT SCIENTIFIC LTD. - 512529 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has, as a part of its investors engagement activities, scheduled a conference call with the Analysts / Investors on Friday, August 11, 2023, to discuss its Q1FY24 financial results SEQUENT SCIENTIFIC LTD. - 512529 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
SEQUENT SCIENTIFIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Meeting of the Board of Directors of SeQuent Scientific Limited is scheduled to be held on Thursday, August 10, 2023 to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30, 2023.
Sequent Scientific shuts operation at Palghar plant; stock rises
Sequent Scientific insisted that the said discontinuation of manufacturing operations will not impact the operations of the Company SEQUENT SCIENTIFIC LTD. - 512529 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Sequent Scientific Limited Regarding Discontinuation Of Operations At The Company''s Manufacturing Unit Located At Tarapur, Maharashtra
Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, we wish to inform you that the Company has discontinued its manufacturing operations at its unit situated at Plot No. W-136 to W-141, W-150 to W-152, MIDC Industrial Area, MIDC Road, Village Saravali, Boisar West, Tarapur, District Palghar, Maharashtra-401506. The said discontinuation of manufacturing operations will not impact the operations of the Company as the production will be absorbed by the Company''s units situated at other locations. This is for your information and records. SEQUENT SCIENTIFIC LTD. - 512529 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate issued in compliance with Regulation 74 (5) of SEBI (Depositories and Participant) Regulation, 2018, by Kfin Technologies Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended June 30, 2023 SEQUENT SCIENTIFIC LTD. - 512529 - Closure of Trading Window
Notice is hereby given that pursuant to the provision of Security and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 read with Company''s code of conduct for Prohibition of Insider Trading, the trading window for all Connected Persons / Designated Persons and their immediate relatives to deal in the securities of the Company shall remain closed from Saturday, July 01, 2023 till 48 hours after declaration of Unaudited Financial Results of the Company for quarter ending on June 30, 2023. The date of the Meeting of Board of Directors of the Company at which the aforesaid Financial Results are to approved, will be intimated to the Stock Exchange in due course. This is for your information and appropriate dissemination. SEQUENT SCIENTIFIC LTD. - 512529 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed Annual Secretarial Compliance Report of Sequent Scientific Limited issued by M/s. Nilesh Shah & Associates, Practicing Company Secretaries, for the year ended March 31, 2023.